Cargando…
The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
The FHIT gene is located at the fragile FRA3B locus where activation by carcinogen-induced and endogenous replication stress causes FHIT deletions even in normal cells over a lifetime. Our lab has shown that loss of FHIT expression causes genome instability and provides single-strand DNA substrates...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731946/ https://www.ncbi.nlm.nih.gov/pubmed/29254236 http://dx.doi.org/10.18632/oncotarget.22321 |
_version_ | 1783286596977557504 |
---|---|
author | Volinia, Stefano Druck, Teresa Paisie, Carolyn A. Schrock, Morgan S. Huebner, Kay |
author_facet | Volinia, Stefano Druck, Teresa Paisie, Carolyn A. Schrock, Morgan S. Huebner, Kay |
author_sort | Volinia, Stefano |
collection | PubMed |
description | The FHIT gene is located at the fragile FRA3B locus where activation by carcinogen-induced and endogenous replication stress causes FHIT deletions even in normal cells over a lifetime. Our lab has shown that loss of FHIT expression causes genome instability and provides single-strand DNA substrates for APOBEC3B hypermutation, in line with evidence that FHIT locus deletions occur in many cancers. Based on these biological features, we hypothesized that FHIT loss drives development of COSMIC mutational signature 5 and here provide evidence, including data mining of >6,500 TCGA samples, that FHIT is the cancer-associated gene with copy number alterations correlating most significantly with signature 5 mutation rate. In addition, tissues of Fhit-deficient mice exhibit a mutational signature strongly resembling signature 5 (cosine similarity value = 0.89). We conclude that FHIT loss is a molecular determinant for signature 5 mutations, which occur in all cancer types early in cancer development, are clock-like, and accelerated by carcinogen exposure. Loss of FHIT caretaker function may be a predictive and preventive marker for cancer development. |
format | Online Article Text |
id | pubmed-5731946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57319462017-12-17 The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles Volinia, Stefano Druck, Teresa Paisie, Carolyn A. Schrock, Morgan S. Huebner, Kay Oncotarget Research Paper The FHIT gene is located at the fragile FRA3B locus where activation by carcinogen-induced and endogenous replication stress causes FHIT deletions even in normal cells over a lifetime. Our lab has shown that loss of FHIT expression causes genome instability and provides single-strand DNA substrates for APOBEC3B hypermutation, in line with evidence that FHIT locus deletions occur in many cancers. Based on these biological features, we hypothesized that FHIT loss drives development of COSMIC mutational signature 5 and here provide evidence, including data mining of >6,500 TCGA samples, that FHIT is the cancer-associated gene with copy number alterations correlating most significantly with signature 5 mutation rate. In addition, tissues of Fhit-deficient mice exhibit a mutational signature strongly resembling signature 5 (cosine similarity value = 0.89). We conclude that FHIT loss is a molecular determinant for signature 5 mutations, which occur in all cancer types early in cancer development, are clock-like, and accelerated by carcinogen exposure. Loss of FHIT caretaker function may be a predictive and preventive marker for cancer development. Impact Journals LLC 2017-11-06 /pmc/articles/PMC5731946/ /pubmed/29254236 http://dx.doi.org/10.18632/oncotarget.22321 Text en Copyright: © 2017 Volinia et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Volinia, Stefano Druck, Teresa Paisie, Carolyn A. Schrock, Morgan S. Huebner, Kay The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles |
title | The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles |
title_full | The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles |
title_fullStr | The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles |
title_full_unstemmed | The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles |
title_short | The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles |
title_sort | ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted fhit alleles |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731946/ https://www.ncbi.nlm.nih.gov/pubmed/29254236 http://dx.doi.org/10.18632/oncotarget.22321 |
work_keys_str_mv | AT voliniastefano theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles AT druckteresa theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles AT paisiecarolyna theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles AT schrockmorgans theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles AT huebnerkay theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles AT voliniastefano ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles AT druckteresa ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles AT paisiecarolyna ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles AT schrockmorgans ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles AT huebnerkay ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles |